Fexofenadine

Contraindicated

Fexofenadine Levoketoconazole Recorlev Increased CYP3A4/P-gp substrate exposure Details

Major

Fexofenadine Cabergoline Dostinex® Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Fexofenadine Capmatinib Tabrecta Increased P-gp substrate exposure and an increased risk of increased adverse reactions Details Fexofenadine Darolutamide Nubeqa Increased exposure of OATP1B1 or OATP1B3 substrates Details Fexofenadine Apalutamide Erleada Reduced OATP1B1/P-gp substrates exposure Details Fexofenadine Apomorphine Apokyn Decreased apomorphine efficacy Details Fexofenadine Berotralstat Orladeyo Increased P-gp substrate exposure Details Fexofenadine Elexacaftor Increased OATP1B1/OATP1B3 substrate exposure Details Fexofenadine Eltrombopag Alvaiz Increased OATP1B1 substrates exposure and an increased risk of OATP1B1 substrates-related adverse reactions Details Fexofenadine Ensitrelvir Increased risk of P-gp substrate exposure Details Fexofenadine Epinephrine Reduced or reversal of EPINEPHrine pressor response Details Fexofenadine Foslevodopa Reduced efficacy of levodopa and an increased risk of exacerbating psychosis (or symptoms of Parkinson's disease: delusion, confus... Details Fexofenadine Itraconazole Sporanox Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Fexofenadine Lenacapavir Sunlenca Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse reactions Details Fexofenadine Leniolisib Joenja Increased OATP1B1/OATP1B3 substrate exposure Details Fexofenadine Levodopa Inbrija Reduced efficacy of levodopa and an increased risk of exacerbating psychosis (or symptoms of Parkinson's disease: delusion, confus... Details Fexofenadine Pitolisant Wakix Reduced efficacy of pitolisant Details Fexofenadine Simeprevir Olysio® Increased exposure of P-gp substrate Details Fexofenadine Venetoclax Venclexta Increased exposure of P-gp substrate and an increased toxicities of these substrates Details Fexofenadine Vimseltinib Romvimza Increased risk of P-gp substrate exposure Details Fexofenadine Voclosporin Lupkynis Increased OATP1B1/OATP1B3 substrate exposure Details Fexofenadine Lenacapavir Injection Sunlenca Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse reactions Details Fexofenadine Lenacapavir Oral Sunlenca Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse reactions Details Fexofenadine Levodopa Oral Inhalation Inbrija Reduced efficacy of levodopa and an increased risk of exacerbating psychosis (or symptoms of Parkinson's disease: delusion, confus... Details

Moderate

Fexofenadine Encorafenib Braftovi Increased OATP1B1 substrate exposure, increased OATP1B3 substrate exposure, increased risk of OATP1B1 substrate-related toxicities... Details Fexofenadine Aluminum Carbonate, Basic Decreased fexofenadine efficacy Details Fexofenadine Aluminum Hydroxide AlternaGEL® Decreased fexofenadine efficacy Details Fexofenadine Aluminum Phosphate Decreased fexofenadine efficacy Details Fexofenadine Dihydroxyaluminum Aminoacetate Decreased fexofenadine efficacy Details Fexofenadine Dihydroxyaluminum Sodium Carbonate Decreased fexofenadine efficacy Details Fexofenadine Levacetylleucine Aqneursa Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Fexofenadine Lomitapide Increased P-gp substrate exposure Details Fexofenadine Magaldrate Decreased fexofenadine efficacy Details Fexofenadine Magnesium Carbonate Decreased fexofenadine efficacy Details Fexofenadine Magnesium Hydroxide Almacone® (containing Aluminum Hydroxide, Magnesium Hydroxide, Simethicone) Decreased fexofenadine efficacy Details Fexofenadine Magnesium Oxide Mag-Ox 400 Decreased fexofenadine efficacy Details Fexofenadine Magnesium Trisilicate Decreased fexofenadine efficacy Details Fexofenadine Sparsentan Filspari Increased P-gp substrate exposure and an increased risk of P-gp substrate-related adverse effects Details Fexofenadine St John's Wort Decreased fexofenadine exposure and effectiveness Details